Image
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Back to top
Prof Robert Landewé
Professor of Rheumatology
Professor Robert Landewé is a professor of rheumatology at the Academic Medical Center at the University of Amsterdam, The Netherlands. His research is in the fields of rheumatoid arthritis and spondyloarthritis, with extensive experience in outcome research and clinical trial design and analysis. Professor Landewé is a board member and former President of the Assessment of SpondyloArthritis International Society (ASAS).
0 resources
Video2 minutes watch
Watch Prof Frank Behrens discuss the importance of treating skin symptoms in addition to musculoskeletal symptoms for patients with SpA.
EU-DA-2400671
Video3 minutes watch
Achieving ACR50 is associated with improvements in quality of life for patients with PsA.1 Dive into the data supporting higher treatment targets in clinical...
EU-DA-2400650
Video3 minutes watch
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss how MDA is a realistic treatment target in clinical practice and the barriers to achieving it for...
EU-DA-2400669
Video2 minutes watch
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
EU-DA-2400668
Video2 minutes watch
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
EU-DA-2400666